Mycophenolate mofetil in neuropsychiatric systemic lupus erythematosus

Indian Journal of Medical Sciences

Volumn 59, Issue 8, 2005, Pages 353-356

  Jose, J ^a   Paulose, B ^a   Vasuki, Z ^a   Danda, D ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

CNS vasculitis; Cyclophosphamide; Mycophenolate mofetil; Systemic lupus erythematosus

Indexed keywords

ANTICOAGULANT AGENT; CITALOPRAM; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NADROPARIN; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; WARFARIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHOREA; CLINICAL FEATURE; FEMALE; HALLUCINATION; HUMAN; INSOMNIA; LABORATORY TEST; MENTAL DISEASE; MICROANGIOPATHY; MOON FACE; NEUROLOGIC DISEASE; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; RESPIRATORY TRACT INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 24344503763     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.16652     Document Type: Article

References (11)

1. Kaposi MK. Nene beitrage zur kenntnis des lupus erythematosus. Arch Derm Syph 1872;4:36-78.
2. Blanco FJ, Gomez-Reino JJ, de la Mata J, Corrales A, Rodriguez-Valverde V, Rosas JC, et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 1998; 7:159-63.
3. McCune WJ, Golbus J: Neuropsychiatric lupus. Rheum Dis Clin North Am 1988; 14:149-167.
4. Isshi K, Hirohata S. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions. Arthritis Rheum. 1998; 41:1819-27.
5. G Sanna, ML Bertolaccini and A.Mathieu. Central Nervous system lupus: a clinical approach to therapy. Lupus 2003;12: 935-942.
6. Shoenfeld Y, Katz U. IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients. Autoimmunity. 2005;38:123-37
7. Toubi E, Kessel A, Shoenfeld Y. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus. Hum Immunol. 2005;66:395-402.
8. Pisoni CN, Sanchez FJ, Karim Y, Cuadrado MJ, D'Cruz DP, Abbs IC, Khamasta MA, Hughes GR Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients. J Rheumatol. 2005;32:1047-52.
9. Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 2003;15:528-34
10. Riskalla MM, Somers EC, Fatica RA, McCune WJ. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus. J Rheumatol. 2003;30:1508-12
11. Grisanti M, Nader A, Cacciuttolo R. Central nervous system involvement due to systemic lupus rythematosus/antiphospholipid syndrome: successful treatment with mycophenolate mofetil. Lupus 2001; 10: S31